HCV in people who inject drugs: A neglected epidemic

The Lancet Infectious Diseases

Volumn 15, Issue 1, 2015, Pages 4-5

  Sarna, Avina ^a   Panda, Samiran ^b  

^a POPULATION COUNCIL   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

DRUG USE; EPIDEMIC; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NEEDLE; NOTE; PREVALENCE; ROOM TEMPERATURE; SUBSTITUTION THERAPY; SYRINGE; COMPLICATION; FEMALE; HEALTH CARE DELIVERY; MALE; SUBSTANCE ABUSE;

FEMALE; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HUMANS; MALE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84917681176     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)71054-0     Document Type: Note

References (12)

1. Only just the beginning of the end of hepatitis C. Lancet 2014, 383:281. The Lancet.
2. Solomon SS, Mehta SH, Srikirishnan AK, et al. High burden of HCV disease and poor access to HCV services among people who inject drugs in India: A cross-sectional study among 14,481 drug users across India. Lancet Infect Dis 2014, published online Dec 3. http://dx.doi.org/10.1016/S1473-3099(14)71054-0.
3. Panda S, Chatterjee A, Sarkar S, et al. Injection drug use in Calcutta: a potential focus for an explosive HIV epidemic. Drug Alcohol Rev 1997, 16:17-23.
4. Eicher AD, Crofts N, Benjamin S, Deutschmann P, Rodger AJ A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India. AIDS Care 2000, 12:497-504.
5. Solomon SS, Srikrishnan AK, Mehta SH, et al. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr 2008, 49:327-332.
6. Panda S, Roy T, Pahari S, et al. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates. Int J STD AIDS 2013, 25:596-606.
7. Platt L, Vickerman P, Collumbien M, et al. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic. Sex Transm Infect 2009, 85(suppl 2):ii17-ii22.
8. Taylor LE, Swan T, Mayer KH HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis 2012, 55(suppl 1):S33-S42.
9. Paintsil E, Binka M, Patel A, Lindenbach BD, Heimer R Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission. J Infect Dis 2014, 209:1205-1211.
10. Sarna A, Tun W, Bhattacharya A, Lewis D, Singh YS, Apicella L Assessment of unsafe injection practices and sexual behaviors among male injecting drug users in two urban cities of India using respondent driven sampling. Southeast Asian Journal of Tropical Medicine & Public Health 2012, 43:652-667.
11. Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010, 375:1014-1028.
12. Palmateer NE, Taylor A, Goldberg DJ, et al. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One 2014, 9:e104515.